3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: Serotonergic involvement

Psychopharmacology

Volumn 161, Issue 4, 2002, Pages 356-364

  Fantegrossi, William E ^a   Ullrich, Thomas ^c   Rice, Kenner C ^c   Woods, James H ^a   Winger, Gail ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Amphetamine; MDMA; Rhesus monkey; Self administration; Serotonin antagonist

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; COCAINE; KETANSERIN; METHAMPHETAMINE; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A RECEPTOR; SODIUM CHLORIDE; DRUG DERIVATIVE; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SELF ADMINISTRATION; ENANTIOMER; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; RHESUS MONKEY; SEROTONINERGIC SYSTEM; STEREOISOMERISM; ANIMAL; MACACA; PHYSIOLOGY; REACTION TIME;

ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MACACA MULATTA; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; REACTION TIME; RECEPTORS, SEROTONIN; REINFORCEMENT (PSYCHOLOGY); SEROTONIN ANTAGONISTS; STEREOISOMERISM; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS; RECEPTOR, SEROTONIN, 5-HT2A;

EID: 0035987117     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1021-6     Document Type: Article

References (42)

1. Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination
2. Assessment of the discriminative stimulus effects of the optical isomers of ecstasy (3,4-methylenedioxymethamphetamine; MDMA)
3. Pharmacologic profile of amphetamine derivatives at various brain recognition sites: Selective effects on serotonin systems
4. 3H]-paroxetine-labeled serotonin uptake sites
5. Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites
6. MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons
7. Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys
8. Methylenedioxymethamphetamine's capacity to establish place preference and modify intake of an alcoholic beverage
9. Use of drugs at "raves"
10. Self-administration of psychoactive substances by the monkey - A measure of psychological dependence
11. 2 antagonists
12. Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs
13. Comparison of behavior maintained by infusions of eight phenylethylamines in baboons
14. 2 receptor agonists
15. Altered serotonin innervation patterns in the forebrain of monkeys treated with (±)-3,4-methylenedioxymethamphetamine seven years previously: Factors influencing abnormal recovery
16. Central nervous system serotonin and personality as variables contributing to excessive alcohol consumption in non-human primates
17. Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: An in vivo microdialysis study
18. Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey
19. The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward
20. 2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats
21. Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon
22. Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") are attenuated by the serotonin uptake inhibitor citalopram
23. Psychological and physiological effects of MDMA ("ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans
24. Serotonergic modulation of 3,4-methylenedioxymethamphetamine (MDMA)-elicited reduction of response rate but not rewarding threshold in accumbal self-stimulation
25. Increased self-administration of d-amphetamine after destruction of 5-hydroxytryptaminergic neurons
26. Reinforcing effects of certain serotonin-releasing amphetamine derivatives
27. 2A receptors attenuates the behavioral effects of cocaine in rats
28. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists
29. Repeated administration of 3,4-methylenedioxymethamphetamine augments cocaine's action on dopamine in the nucleus accumbens: A microdialysis study
30. Structure-activity relationships of MDMA and related compounds: A new class of psychoactive agents?
31. Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats
32. Lasting effects of (±)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: Neurochemical observations
33. The molecular mechanism of [3,4-methylenedioxy-methamphetamine (MDMA)]: Serotonin transporters are targets for MDMA-induced serotonin release
34. 2 receptors: Implications for treating LSD-induced hallucinogenesis
35. Intravenous self-injection of four novel phenethylamines in baboons
36. 2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine
37. Oral ethanol self-administration in rhesus monkeys: Behavioral and neurochemical correlates
38. Inhibitory effects of dopamine and methylenedioxymethamphetamine (MDMA) on glutamate-evoked firing of nucleus accumbens and caudate/putamen cells are enhanced following cocaine self-administration
39. Drug-reinforced responding: Rapid determination of dose-response functions
40. Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys
41. Fenfluramine: Amphetamine congener that fails to maintain drug-taking behavior in the rhesus monkey
42. Intravenous self-administration of R(-)-cathinone and 2-amino-1-(2,5-dimethoxy-4-methyl) phenylpropane in rhesus monkeys